4.4 Article

HIV exposed seronegative individuals show antibodies specifically recognizing native HIV envelope glycoprotein

Journal

AIDS
Volume 27, Issue 9, Pages 1375-1385

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/QAD.0b013e32835fac08

Keywords

conformational epitopes; natural antibodies; protection; soluble CD4-induced epitopes transmission

Funding

  1. HIVACAT Program
  2. Spanish AIDS network 'Red Tematica Cooperativa de Investigacion en SIDA' [RD06/0006]
  3. Fondo de Investigaciones Sanitarias [PI050283]
  4. ISCIII
  5. Health Department of the Catalan Government (Generalitat de Catalunya)
  6. Health Department of the Community of Madrid
  7. 'Sara Borrell' grant from the Spanish Health Institute 'ISCIII'
  8. Generalitat de Catalunya
  9. European Social Fund
  10. Fundacion para la Investigacion y Educacion del SIDA en Espana (IES foundation)

Ask authors/readers for more resources

Background: Susceptibility to HIV transmission by sexual intercourse has been associated with cellular anti-HIV responses. We aimed to also evaluate potential systemic humoral responses against HIV in a group of HIV-exposed seronegative individuals (HESN) in stable relationship with HIV-infected partners. Methods: We recruited 27 serodiscordant couples. HESN were classified according to HIV exposure into very low/low and moderate/high risk. Plasma from HESN and HIV+ partners were tested for neutralizing capacity and for the recognition of cell-surface expressed and recombinant forms of HIV envelope glycoproteins (Env). Healthy individuals (healthy control, n = 11) were used as controls. Results: Recognition of cell-surface expressed Env by both immunoglobulin (Ig) G and IgA was higher in plasma samples from HESN than in healthy controls (P = 0.0062 and P = 0.0144, respectively). IgG binding to Env was significantly increased in HESN after unmasking CD4-induced epitopes (P = 0.001), suggesting a wide range of targeted epitopes. Remarkably, ELISA assays using trimeric gp140 or monomeric gp120 failed to detect significant differences in reactivity between groups. Neutralization analysis showed residual activity in only three HESN samples (11%), whereas 70% of HIV-infected partners showed neutralizing activity. Although anti-Env humoral responses were found in 85% of HESN, their magnitude was not associated with the estimated level of exposure or the detection of HIV-specific cellular immune responses. Conclusion: A high proportion of HESN show detectable plasma IgG or IgA recognizing different exposed and cryptic Env native epitopes unrelated to neutralizing capacity. Therefore, low but persistent HIV exposure induces new virus-specific systemic humoral responses or boosts preexisting natural antibodies. (C) 2013 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Medicine, General & Internal

Predictors of in-hospital mortality in HIV-infected patients with COVID-19

Victor Moreno-Torres, Carmen de Mendoza, Maria Martinez-Urbistondo, Patricia Mills, Ana Trevino, Sara de la Fuente, Alberto Diaz de Santiago, Jorge Calderon-Parra, Ilduara Pintos-Pascual, Manuel Corpas, Vicente Soriano

Summary: HIV-infected patients hospitalized in Spain with COVID-19 during 2020 had lower mortality rate compared to HIV-negatives, likely due to younger age and lower rate of comorbidities. However, advanced liver disease was a major predictor of death in HIV-infected patients hospitalized with COVID-19.

QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2023)

Article Oncology

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors

Eudald Felip, Edwards Pradenas, Margarita Romeo, Silvia Marfil, Benjamin Trinite, Victor Urrea, Ainhoa Hernandez, Ester Ballana, Marc Cucurull, Lourdes Mateu, Marta Massanella, Bonaventura Clotet, Teresa Moran, Julia Blanco

Summary: Patients with solid tumors have a higher risk of complications, hospitalizations, or death during the SARS-CoV-2 pandemic. The immunosuppressive state of cancer treatments or the tumor itself may affect the development of vaccination antibodies. This study emphasizes the importance of prioritizing cancer patients receiving anticancer treatment in SARS-CoV-2 vaccination programs.

MOLECULAR ONCOLOGY (2023)

Article Immunology

Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study

Victor Moreno-Torres, Vicente Soriano, Jorge Calderon-Parra, Maria Martinez-Urbistondo, Ana Trevino, Zayrho de San Vicente, Carmen de Mendoza, Guillermo Ruiz-Irastorza

Summary: A retrospective nationwide observational analysis in Spain found an increased incidence of giant-cell arteritis (GCA) and associated stroke after SARS-CoV-2 infection and COVID-19 vaccination. The study compared hospital admissions for GCA between pre-pandemic (2016-2019) and pandemic (2020-2021) years. The incidence of GCA and GCA-associated stroke was higher during the pandemic years, particularly during the third wave of COVID-19 and the third dose vaccination in patients older than 70. The findings suggest a potential link between COVID-19 and mRNA-SARS-CoV-2 vaccines with an increased risk of GCA and stroke.

AUTOIMMUNITY REVIEWS (2023)

Article Oncology

Alanine-based spacers promote an efficient antigen processing and presentation in neoantigen polypeptide vaccines

Carmen Aguilar-Gurrieri, Ana Barajas, Carla Rovirosa, Raquel Ortiz, Victor Urrea, Nuria de la Iglesia, Bonaventura Clotet, Julia Blanco, Jorge Carrillo

Summary: Neoantigens are tumor-specific antigens that can elicit a specific immune response. They have potential for the development of personalized cancer vaccines. The presentation of neoantigens to T cells is influenced by vaccine delivery strategies, including the use of specific linkers. The efficiency of neoantigen processing and presentation by MHC-I molecules can be improved with alanine-based linkers.

CANCER IMMUNOLOGY IMMUNOTHERAPY (2023)

Review Pharmacology & Pharmacy

Safety considerations in the management of hepatitis C and HIV co-infection

Vicente Soriano, Victor Moreno-Torres, Ana Trevino, Pablo Barreiro, Fernando de Jesus, Octavio Corral, Carmen de Mendoza

Summary: HCV and HIV are highly prevalent infections worldwide. Oral antivirals can cure HCV and slow down disease progression in HIV patients. However, dual therapy for HCV and HIV presents challenges such as drug-related side effects, hepatitis B reactivation, immune reconstitution inflammatory syndromes (IRIS), and drug-drug interactions (DDI).

EXPERT OPINION ON DRUG SAFETY (2023)

Article Psychology, Clinical

Evidence for feasibility of implementing online brief cognitive-behavioral therapy for eating disorder pathology in the workplace

Carla T. Toro, Agatha Payne, Tabitha Jackson, Sean Russell, Guy Daly, Glenn Waller, Caroline Meyer

Summary: CBT-T is a brief cognitive-behavioral therapy for non-underweight eating disorders. This report describes the findings from a feasibility trial of online CBT-T in the workplace as an alternative to health service settings. The trial showed high feasibility and acceptability with positive impacts on eating pathology, anxiety, depression, and work outcomes. Rating: 8/10

INTERNATIONAL JOURNAL OF EATING DISORDERS (2023)

Review Infectious Diseases

Determinants of poor clinical outcome in patients with influenza pneumonia: A systematic review and meta-analysis

Javier Arranz-Herrero, Jesus Presa, Sergio Rius-Rocabert, Alberto Utrero-Rico, Jose Angel Arranz-Arija, Antonio Lalueza, Maria M. Escribese, Jordi Ochando, Vicente Soriano, Estanislao Nistal-Villan

Summary: The clinical burden of influenza is increasing worldwide, with bacterial infections being the main cause of complications and poor clinical outcomes. Streptococcus pneumoniae and Staphylococcus aureus are the most common microorganisms causing bacterial infections in patients with influenza. Early diagnosis and use of antibiotics can improve outcomes in this population.

INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2023)

Article Biochemistry & Molecular Biology

Exploring FeLV-Gag-Based VLPs as a New Vaccine Platform-Analysis of Production and Immunogenicity

Raquel Ortiz, Ana Barajas, Anna Pons-Grifols, Benjamin Trinite, Ferran Tarres-Freixas, Carla Rovirosa, Victor Urrea, Antonio Barreiro, Anna Gonzalez-Tendero, Maria Cardona, Laura Ferrer, Bonaventura Clotet, Jorge Carrillo, Carmen Aguilar-Gurrieri, Julia Blanco

Summary: Feline leukemia virus (FeLV) is a common infectious disease in domestic cats, and current vaccines do not provide full protection. This study proposes using HIV-1 Gag-based VLPs as a novel vaccine strategy against FeLV. The immunogenicity of selected candidates was evaluated in mice, showing strong immune responses to Gag but failing to generate antibodies against p15E.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Gastroenterology & Hepatology

Susceptibility to hepatitis B virus infection in adults living in Spain

Vicente Soriano, Antonio Aguilera, Rafael Benito, Rocio Gonzalez-Diez, Elisenda Miro, Paloma Liendo, Juan Carlos Rodriguez-Diaz, Teresa Cabezas, Alberto Richart, Jose Manuel Ramos, Luisa Barea, Carmen Alvarez, Ana Trevino, Felix Gomez-Gallego, Octavio Corral, Carmen de Mendoza

Summary: In Spain, the proportion of adults vaccinated against hepatitis B is still low, with approximately 60% of adults at risk for hepatitis B. Therefore, it is recommended to conduct HBV serological testing and administer HBV vaccines or boosters to all adults.

LIVER INTERNATIONAL (2023)

Article Multidisciplinary Sciences

Cyanovirin-N binds to select SARS-CoV-2 spike oligosaccharides outside of the receptor binding domain and blocks infection by SARS-CoV-2

Jordana Munoz-Basagoiti, Fabio Luis Lima Monteiro, Lauren R. H. Krumpe, Victoria Armario-Najera, Shilpa R. Shenoy, Daniel Perez-Zsolt, Harrison James Westgarth, Gemma Villorbina, Larissa Maciel Bomfim, Dalia Raich-Regue, Lara Nogueras, Curtis J. Henrich, Marcal Gallemi, Filipe Romero Rebello Moreira, Pascual Torres, Jennifer Wilson, Mirela D'arc, Silvia Marfil, Alice Laschuk Herlinger, Edwards Pradenas, Luiza Mendonca Higa, Manuel Portero-Otin, Benjamin Trinite, Richard M. Twyman, Teresa Capell, Amilcar Tanuri, Julia Blanco, Nuria Izquierdo-Useros, Elibio L. Rech, Paul Christou, Barry R. O'Keefe

Summary: SARS-CoV-2 is a coronavirus responsible for the COVID-19 pandemic. Targeting the glycosylated Spike protein on the virus surface can prevent infections. Cyanovirin-N (CV-N), a lectin from cyanobacteria, can selectively target SARS-CoV-2 Spike glycans and inhibit viral infection in vitro and in vivo, showing potential as a broad-spectrum antiviral agent.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2023)

Review Immunology

Syphilis vaccine: challenges, controversies and opportunities

Carlos Avila-Nieto, Nuria Pedreno-Lopez, Oriol Mitja, Bonaventura Clotet, Julia Blanco, Jorge Carrillo

Summary: Syphilis is a sexually or vertically transmitted disease caused by Treponema pallidum subspecie pallidum (TPA) infection. Despite being an obligate human pathogen with a well-known infection route and effective treatment options, the incidence of syphilis has been increasing. Developing a syphilis vaccine is crucial in countries where current preventive measures are limited. Although previous vaccine prototypes in preclinical studies did not provide full protection against infection, they showed promising results in preventing bacteria dissemination and attenuating lesion development. It is important to integrate knowledge about TPA immune response and outer membrane protein (OMP) characterization to expedite vaccine development.

FRONTIERS IN IMMUNOLOGY (2023)

Article Medicine, General & Internal

Macrophage CD5L is a target for cancer immunotherapy

Lidia Sanchez-Moral, Tony Paul, Clara Martori, Joan Font-Diaz, Lucia Sanjurjo, Gemma Aran, Erica Tellez, Julia Blanco, Jorge Carrillo, Masaoki Ito, Martina Tuttolomondo, Henrik J. Ditzel, Caterina Fumagalli, Gustavo Tapia, Julia Sidorova, Helena Masnou, Marco-Antonio Fernandez-Sanmartin, Juan-Jose Lozano, Cristina Vilaplana, Alheli Rodriguez-Cortes, Carolina Armengol, Annabel F. Valledor, Leonor Kremer, Maria-Rosa Sarriasa

Summary: This study explores the role of macrophage CD5L protein in tumor-associated macrophage (TAM) activity and its potential as a therapeutic target. Results show that cancer cell lines induce an immunosuppressive phenotype in macrophages through increased CD5L expression. High TAM expression of CD5L is associated with poor patient outcomes in lung adenocarcinoma. Researchers developed an anti-CD5L monoclonal antibody that blocks the immunosuppressive phenotype in macrophages and inhibits tumor progression in vivo.

EBIOMEDICINE (2023)

Article Virology

Adult T-cell leukemia/lymphoma in HTLV-1 non-endemic regions

Carmen de Mendoza, Ariadna Rando, Elisenda Miro, Maria Jose Pena, Iciar Rodriguez-Avial, Diego Ortega, Alejandro Gonzalez-Praetorius, Gabriel Reina, Ilduara Pintos, Maria Jose Pozuelo, Vicente Soriano

Summary: The rate of ATLL is very low in Spain and mostly associated with migrants from HTLV-1 endemic regions. ATLL patients have a poor clinical outcome, with most of them dying within one year. In Spain, HTLV-1 testing should be performed on migrants from HTLV-1 endemic countries and natives who have lived in or had sex partners from such regions.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Virology

Impact of the COVID-19 pandemic on hospital admissions due to viral hepatitis in Spain

Jose Manuel Ramos-Rincon, Hector Pinargote-Celorio, Carmen de Mendoza, Clara Ramos-Belinchon, Victor Moreno-Torres, Ana Trevino, Pablo Barreiro, Octavio Corral, Vicente Soriano

Summary: Hospitalizations due to viral hepatitis significantly declined in Spain during the COVID-19 pandemic. Patients admitted with viral hepatitis experienced a greater mortality during the pandemic period. Deaths were more pronounced when co-infected with SARS-CoV-2 despite having advanced liver disease less frequently.

JOURNAL OF CLINICAL VIROLOGY (2023)

Article Immunology

Immunogenicity and safety in pigs of PHH-1V, a SARS-CoV-2 RBD fusion heterodimer vaccine candidate

Alexandra Moros, Antoni Prenafeta, Antonio Barreiro, Eva Perozo, Alex Fernandez, Manuel Canete, Luis Gonzalez, Carme Garriga, Edwards Pradenas, Silvia Marfil, Julia Blanco, Paula Cebollada Rica, Marta Sistere-Oro, Andreas Meyerhans, Teresa Prat Cabanas, Ricard March, Laura Ferrer

Summary: The development of a new generation of efficacious vaccines is crucial due to the high global incidence of COVID-19 and low vaccination rates. Researchers have developed an adjuvanted vaccine candidate, PHH-1V, based on a protein fusion of the receptor binding domain (RBD) from the Beta variant of SARS-CoV-2 and the equivalent domain from the Alpha variant. In pig models, PHH-1V has demonstrated excellent safety and has induced a robust immune response to SARS-CoV-2, including neutralising antibodies to multiple variants.

VACCINE (2023)

No Data Available